Abstract
Analysis of drug prescription appropriateness in the integrated management of dementia in a Health District of Modena
Highlights
In the province of Modena an agreement between the Local Authority for Health of Modena and the General Practioners (GPs) is in force since 2002
To verify the frequency of the prescription and side effects of three classes of drugs commonly used in people with dementia and to relate these data to some indicators judged important for the quality of care and of life of the patient and his family (severity of dementia, disease progression, the presence of behavioural and psychological symptoms of dementia (BPSD) and the family’s endurance to care for the patient at home)
In 7 cases (1%) data are missing on prescription of psychotropic drugs. 34.5% (n = 249) of the patients takes an anti-dementia drug, 28.7% (n = 207) are treated with antipsychotics and 56.8% (n = 406) with antidepressants, with a higher prevalence in women
Summary
In the province of Modena an agreement between the Local Authority for Health of Modena and the General Practioners (GPs) is in force since 2002. Aims: To verify the frequency of the prescription and side effects of three classes of drugs commonly used in people with dementia (cholinesterase inhibitors and Memantine, first and second generation antipsychotics and antidepressants) and to relate these data to some indicators judged important for the quality of care and of life of the patient and his family (severity of dementia, disease progression, the presence of behavioural and psychological symptoms of dementia (BPSD) and the family’s endurance to care for the patient at home).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
